Diagnostic Contract Manufacturing Market Size, Share & Trends Analysis Report By Device (In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), Other Devices), By Service (Device Development & Manufacturing, Quality Management, Packaging & Assembly), By Application, By Region, And By Segment Forecasts, 2024-2031.

Report Id: 2449 Pages: 180 Last Updated: 05 February 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Diagnostic Contract Manufacturing Market-

Diagnostic Contract Manufacturing Market By Device-

  • In Vitro Diagnostic Devices
    • IVD Consumables
    • IVD Equipment
  • Diagnostic Imaging Devices
    • X-ray
    • CT scan
    • Ultrasound
    • MRI
    • Others
  • Other Devices

Diagnostic Contract Manufacturing Market seg

Diagnostic Contract Manufacturing Market By Service-

  • Device Development & Manufacturing
  • Quality Management
  • Packaging & Assembly

Diagnostic Contract Manufacturing Market By Application-

  • In Vitro Diagnostic Devices
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Others
  • Diagnostic Imaging Devices
    • Cardiology
    • Neurology
    • Orthopedics
    • Oncology
    • Others
  • Other Devices
    • Gastroenterology
    • Gynecology
    • Others

Diagnostic Contract Manufacturing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Diagnostic Contract Manufacturing Market Snapshot

Chapter 4. Global Diagnostic Contract Manufacturing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis

5.1. by Product & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product:

5.2.1. In Vitro Diagnostic Devices

5.2.1.1. IVD Consumables

5.2.1.2. IVD Equipment

5.2.2. Diagnostic Imaging Devices

5.2.2.1. CT

5.2.2.2. X-ray

5.2.2.3. Ultrasound

5.2.2.4. MRI

5.2.2.5. Others

5.2.3. Other Devices

Chapter 6. Market Segmentation 2: by Service Estimates & Trend Analysis

6.1. by Service & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Service:

6.2.1. Device Development and Manufacturing Services

6.2.2. Quality Management Services

6.2.3. Packaging and Assembly Services

6.2.4. Other Services

Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis

7.1. by Application & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

7.2.1. In Vitro Diagnostic Devices

7.2.1.1. Infectious Diseases

7.2.1.2. Diabetes

7.2.1.3. Oncology

7.2.1.4. Cardiology

7.2.1.5. Other Applications

7.2.2. Diagnostic Imaging Device

7.2.2.1. Cardiology

7.2.2.2. Oncology

7.2.2.3. Orthopedics

7.2.2.4. Neurology

7.2.2.5. Other Applications

7.2.3. Other Devices

7.2.3.1. Gastroenterology

7.2.3.2. Gynecology

7.2.3.3. Other Application

Chapter 8. Diagnostic Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.1.2. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.1.3. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.1.4. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.2.2. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.2.3. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.2.4. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.3.2. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.3.3. Asia-Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.3.4. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.4.2. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.4.3. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.4.4. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.5.2. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.5.3. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.5.4. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Jabil Inc.

9.2.2. Flex Ltd.

9.2.3. Plexus Corp

9.2.4. Sanmina Corporation

9.2.5. TE Connectivity Ltd.

9.2.6. Celestica Inc.

9.2.7. Integer Holdings Corporation

9.2.8. Nipro Medical Corporation

9.2.9. Thermo Fisher Scientific

9.2.10. West Pharmaceutical Services, Inc.

9.2.11. Benchmark Electronics Inc.

9.2.12. Kimball Electronics Inc.

9.2.13. KMC Systems

9.2.14. Savyon Diagnostics

9.2.15. Nova Biomedical

9.2.16. Cenogenic Corporation

9.2.17. Cone Bioproducts

9.2.18. Avioq Inc.

9.2.19. Philips-Medisize Corporation

9.2.20. Invetech

9.2.21. Meridian Bioscience, Inc.

9.2.22. Nolato AB

9.2.23. Fujirebio

9.2.24. Sekisui

9.2.25. Prestige Diagnostics

9.2.26. Biokit

9.2.27. Other Market Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6594
Security Code field cannot be blank!

Frequently Asked Questions

Diagnostic Contract Manufacturing Market Size is valued at USD 25.7 Bn in 2023 and is predicted to reach USD 57.9 Bn by the year 2031

Diagnostic Contract Manufacturing Market is expected to grow at a 10.78% CAGR during the forecast period for 2024-2031.

Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, B
Get Sample Report Enquiry Before Buying